🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 87 of 114

  1. Sparsentan_DF2, IRBESARTAN, Sparsentan_DF3

    Travere Therapeutics

    Focal segmental glomerulosclerosis (FSGS)

    phase 3 small molecule active

    1 trial

  2. Spesolimab - solution for infusion

    Boehringer Ingelheim

    Netherton Syndrome

    phase 3 small molecule terminated

    1 trial

  3. Spesolimab i.v.

    Boehringer Ingelheim

    Hidradenitis Suppurativa

    phase 3 small molecule completed

    1 trial

  4. Spesolimab, Placebo matching to Spesolimab

    Boehringer Ingelheim

    Hidradenitis Suppurativa (HS)

    phase 3 small molecule active

    1 trial

  5. Spironolactone

    Takeda

    Atrial Fibrillation

    phase 3 small molecule active

    1 trial

  6. Spravato 28 mg nasal spray, solution, Midazolam-ratiopharm® 2 mg/ml orale Lösung, Oral placebo, Intranasal Placebo

    Janssen-Cilag International N.V.

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  7. St Thomas

    Jazz Pharmaceuticals Ireland Limited

    Coronary Artery Stenosis

    phase 3 small molecule completed

    1 trial

  8. Standard Brief Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Usage

    phase 3 other completed

    1 trial

  9. Standard Care

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 other completed

    1 trial

  10. Standard Care Intervention (SCI)

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 3 other completed

    1 trial

  11. Standard First-Line Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unresectable Colorectal Cancer

    phase 3 small molecule active

    1 trial

  12. Standard of Care

    Telix Innovations

    Metastatic Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  13. Standard of Care

    AbbVie

    Non-Squamous Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  14. Standard of Care PO (oral) antibiotics

    United Therapeutics Europe Ltd

    Infections

    phase 3 small molecule active

    1 trial

  15. Standard of Care Treatment

    Kyverna Therapeutics

    Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  16. Standard treatment: Control arm

    United Therapeutics Europe Ltd

    Cervical Carcinoma

    phase 3 other active

    1 trial

  17. Start antiplatelet monotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracerebral Hemorrhage

    phase 3 small molecule completed

    1 trial

  18. Statins

    Arrowhead Pharmaceuticals Ireland Limited

    Intracerebral Hemorrhage

    phase 3 small molecule active

    1 trial

  19. StemEx®

    Teva Pharma GmbH

    Hematologic Malignancies

    phase 3 small molecule completed

    1 trial

  20. Stereotactic Radiation Therapy

    GT Biopharma

    Brain Metastases

    phase 3 other active

    1 trial

  21. Sterile 0.9% (w/v) sodium chloride solution in single-use PFS, Novolizer Salbutamol 100 microgrammes/dose, poudre pour inhalation

    GlaxoSmithKline

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule active

    1 trial

  22. Sterile normal saline (0.9% sodium chloride solution), ADX-324

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema

    phase 3 small molecule active

    1 trial

  23. Steroid nasal spray

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-Induced Mucositis

    phase 3 small molecule active

    1 trial

  24. Stimus (NNG-DEPO)

    Biotech Pharmaceutical Co.,

    Anemia

    phase 3 mab completed

    1 trial

  25. Subcutaneous Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Metastatic Gastric Adenocarcinoma

    phase 3 small molecule active

    1 trial

  26. Sublingual film containing Dexmedetomidine (BXCL501)

    BioXcel Therapeutics

    Agitation Associated With Bipolar Disorder

    phase 3 small molecule completed

    1 trial

  27. Sublingual film containing dexmedetomidine (BXCL501)

    BioXcel Therapeutics

    Agitation

    phase 3 small molecule completed

    1 trial

  28. Subxiphoid uniportal VATS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Neoplasms

    phase 3 other completed

    1 trial

  29. Subxiphoid uniportal VATS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mediastinal Neoplasms

    phase 3 other active

    1 trial

  30. Sufentanil 30 MCG Sublingual Tablet

    United Therapeutics Europe Ltd

    Traumatic Injury

    phase 3 small molecule completed

    1 trial

  31. Sufentanil Mylan 50 microgrammes/ml solution injectable, MORPHINE HYDROCHLORIDE, CHLORURE DE SODIUM 0,9 % LAVOISIER, solution pour perfusion

    Pari Pharma GmbH

    vaso-occlusive crisis due to sickle cell disease

    phase 3 small molecule active

    1 trial

  32. Sugammadex 100 mg/ml solution for injection, Rocuronium bromide 10 mg/ml solution for injection/infusion

    Istituto Gentili S.r.l.

    patients scheduled to undergo elective surgical procedures with general anesthesia

    phase 3 small molecule active

    1 trial

  33. Sulopenem

    Iterum Therapeutics plc

    Complicated Urinary Tract Infections

    phase 3 small molecule completed

    1 trial

  34. Sulopenem etzadroxil/probenecid

    Iterum Therapeutics plc

    Urinary Tract Infections

    phase 3 small molecule completed

    1 trial

  35. Sulopenem-Etzadroxil/Probenecid

    Iterum Therapeutics plc

    Uncomplicated Urinary Tract Infections

    phase 3 small molecule completed

    1 trial

  36. Sunitinib AqVida 12,5 mg Hartkapseln, QINLOCK 50 mg tablets

    Lacuna Pharma Pty Ltd

    Patients with Advanced Gastrointestinal Stromal Tumors

    phase 3 small molecule active

    1 trial

  37. Sunlenca 300 mg film-coated tablets, BICTEGRAVIR 75 MG/LENACAPAVIR 50 MG FDC TABLETS

    Gilead Sciences Pty Limited

    HIV-1 Infection

    phase 3 small molecule active

    1 trial

  38. Supportive care+Prednisone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Minimal Change Disease

    phase 3 small molecule active

    1 trial

  39. Suprefact Depot 9,45 mg implantat, Pamorelin 11,25 mg, poeder en oplosmiddel voor suspensie voor injectie, met verlengde afgifte., Pamorelin 22,5 mg, poeder en oplosmiddel voor suspensie voor injectie, met verlengde afgifte., Pamorelin 3,75 mg, poeder en oplosmiddel voor suspensie voor injectie, met verlengde afgifte., Eligard 45 mg poeder en oplosmiddel voor oplossing voor injectie, LEUPRORELIN ACETATE, CAMCEVI 42 mg prolonged-release suspension for injection, Gonapeptyl Depot 3,75 mg poeder en oplosmiddel

    Disc Medicine

    low-volume metastatic castration-sensitive prostate cancer

    phase 3 small molecule active

    1 trial

  40. Suptavumab 30 mg/kg

    Regeneron UK Limited

    Respiratory Syncytial Virus Infections

    phase 3 small molecule completed

    1 trial

  41. Surgery and HIPEC with Lobaplatin

    Universal Integrated

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  42. Surgery with an external ring fixator

    United Therapeutics Europe Ltd

    Severe Open Fractures of the Tibia (Shin) Bone

    phase 3 other completed

    1 trial

  43. Surovatamig

    AstraZeneca

    Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV

    phase 3 small molecule active

    1 trial

  44. Suspension of autologous mononuclear cells separated from bone marrow aspirate

    The George Institute

    diabetic foot syndrome, lower limb ischemia

    phase 3 small molecule active

    1 trial

  45. Sutent 12.5 mg hard capsules, KEYTRUDA 25 mg/mL concentrate for solution for infusion, PAZOPANIB , Sutent 25 mg hard capsules

    Incyte

    Locally advanced/metastatic renal cell carcinoma

    phase 3 small molecule active

    1 trial

  46. Sutent 50 mg hard capsules, Alectinib (Alecensa), Sutent 12.5 mg hard capsules, Cotellic, Sutent 25 mg hard capsules, RO7047650, Cotellic, Alecensa 150 mg hard capsules, Tecentriq 1 200 mg concentrate for solution for infusion, Zelboraf, Sutent 12.5 mg hard capsules, Venclexta, Venclyxto, Alecensa 150 mg hard capsules, Paclitaxel 6 mg/ml Concentrate for Solution for Infusion, RO7250726, Sutent 25 mg hard capsules, ALIMTA 500 mg powder for concentrate for solution for infusion, Sutent 50 mg hard capsules, Ze

    Hoffmann-La Roche

    Advanced Malignancies

    phase 3 small molecule active

    1 trial

  47. Suxiao Jiuxin Pill

    The First People's Hospital of Lianyungang

    Acute Mountain Sickness

    phase 3 small molecule active

    1 trial

  48. Suzetrigine

    Vertex Pharmaceuticals (Australia) Pty.

    Diabetic Peripheral Neuropathic Pain

    phase 3 small molecule active

    3 trials

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.